Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial

Published:2022-10 Issue:10 Volume:22 Page:1472-1483
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Cotton Mark F,Madhi Shabir A,Luabeya Angelique K,Tameris Michele,Hesseling Anneke C,Shenje Justin,Schoeman Elisma,Hatherill Mark,Desai Sajjad,Kapse Dhananjay,Brückner Sina,Koen Anthonet,Jose Lisa,Moultrie Andrew,Bhikha Sutika,Walzl Gerhard,Gutschmidt Andrea,Kotze Leigh A,Allies Devon L,Loxton Andre G,Shaligram Umesh,Abraham Maria,Johnstone Hilary,Grode Leander,Kaufmann S H E,Kulkarni Prasad S

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference31 articles.

1. Moving tuberculosis vaccines from theory to practice;Andersen;Nat Rev Immunol,2019

2. La vaccination préventive contre la tuberculose par le “BCG”;Calmette,1927

3. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette–Guérin mutants that secrete listeriolysin;Grode;J Clin Invest,2005

4. Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis;Scriba;Semin Immunol,2020

5. Vaccination against tuberculosis: revamping BCG by molecular genetics guided by immunology;Kaufmann;Front Immunol,2020

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent efforts in the development of glycoconjugate vaccine and available treatment for tuberculosis;Bioorganic Chemistry;2024-09

2. Bactofection, Bacterial-Mediated Vaccination, and Cancer Therapy: Current Applications and Future Perspectives;Vaccines;2024-08-27

3. Selenium nanoparticles enhance mucosal immunity against Mycobacterium bovis infection;International Immunopharmacology;2024-08

4. From pathogenesis to antigens: the key to shaping the future of TB vaccines;Frontiers in Immunology;2024-07-23

5. Optimizing antigen selection for the development of tuberculosis vaccines;Cell Insight;2024-06